Tratamiento de la fibrosis hepática

Solís Herruzo, José Antonio; Solís-Muñoz, Pablo; Muñoz Yagüe, Teresa.
Gastroenterol. hepatol. (Ed. impr.) ; 34(cong.1): 37-50, feb. 2011.
Artículo en Español | IBECS (España) | ID: ibc-104238

Documentos relacionados

  1. Effects of metabolic syndrome on renal stone progression.
  2. The elevation of fibroblast growth factor 21 is associated with generalized periodontitis in patients with treated metabolic syndrome.
  3. Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2.
  4. Increasing the efficiency of hypolipidemic therapy with the combined use of quercetin in patients with non-alcoholic fatty liver disease on the background of the metabolic syndrome.
  5. [The role of antioxidants in the therapy of metabolic syndrome in men].
  6. Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIV.
  7. CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE.
  8. Current views on metabolic syndrome.
  9. Obesity-related asthma: new insights leading to a different approach.
  10. Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis.